Legal status by country
Is Sermorelin / GHRP legal?
Written by Aaron CuhaReviewed Sep 2026
How Sermorelin / GHRP is classified in the United States, United Kingdom, Australia and Canada, side by side. Each country has its own page with a direct answer, the regulator's approval status and what the classification means in practice.
All four countries, side by side
| Attribute | United States · FDA | United Kingdom · MHRA | Australia · TGA | Canada · Health Canada |
|---|---|---|---|---|
| Status | Prescription route | Not approved | Not approved | Not approved |
| Classification | No approved blend; sermorelin is available compounded | Not licensed | Not approved | Not approved |
| Note | Sermorelin's prior approval as Geref was discontinued and it is supplied through compounding pharmacies. GHRP-2 and GHRP-6 are not FDA-approved. Compounded blends are not reviewed by the FDA for safety, purity or efficacy. | No licensed product. Unlicensed supply for human use is unlawful. | Not approved. Prohibited in sport by class (WADA S2). | Not approved. |
US FDA status: Not approved as a blend. Sermorelin was previously FDA-approved as Geref and is now supplied compounded; GHRP-2 is approved in Japan as a diagnostic agent only; GHRP-6 is not approved anywhere.. Reviewed Sep 2026.
Related compounds
General information current as of Sep 2026, not legal advice. Classifications change; confirm with the regulator or a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships.